• Publications
  • Influence
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
TLDR
The aim of this work is to provide a systematic review and meta-analysis of the literature on canine coronavirus infection and its role in infertility and procreation that has been reported on in previous studies and is concerned with the well-being of newborns. Expand
Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy
TLDR
TnI release pattern after high-dose chemotherapy identifies patients at different risks of cardiac events in the 3 years thereafter, and stratification allows the monitoring program and to plan, in selected patients, preventive strategies aimed at improving clinical outcome. Expand
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.
TLDR
In patients with FL, the administration of 4 additional doses of rituximab at 8-week intervals significantly improves the EFS andCirculating normal B lymphocytes and immunoglobulin M plasma levels decreased for a significantly longer time after prolonged treatment, but the incidence of adverse events was not increased. Expand
Breast cancer in pregnancy: recommendations of an international consensus meeting.
TLDR
The treatment of breast cancer in pregnancy should be executed by experienced specialists in a multidisciplinary setting and should adhere as closely as possible to standard protocols. Expand
Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.
TLDR
Pregnancy after ER-positive BC does not seem to reduce the risk of BC recurrence, and DFS in the whole population, and overall survival (OS) were secondary objectives. Expand
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
TLDR
For Advanced Breast Cancer (ABC 3) F. Cardoso, A. Costa, E. Senkus, M. Mayer, H. Meijer, S. Shockney, G. Sledge, C. Tutt, D. Vorobiof, B. Xu, L. Norton & E. Winer European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Expand
No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a
TLDR
The first long-term analysis confirming that GnRHa is not efficient in preventing chemotherapy-induced POF in young patients with lymphoma and did not influence future pregnancy rate is reported, reopen the debate about the drug's benefit. Expand
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).
• This ESO-ESMO ABC 5 Clinical Practice Guideline provides key recommendations for managing advanced breast cancer patients. • It provides updates on managing patients with all breast cancerExpand
Cancer and fertility preservation: international recommendations from an expert meeting
TLDR
Although there is a great interest in this field, due to the lack of large prospective cohort studies and randomized trials on these topics, the level of evidence is not higher than 3 for most of the recommendations highlighting the need of further research efforts in many areas of this field. Expand
Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type.
TLDR
It is indicated that rituximab is safe with significant activity in MALT lymphomas with a response rate significantly higher in the chemotherapy-naive patients, who had an 87% response rate compared with 45% of the previously treated patients. Expand
...
1
2
3
4
5
...